Domains



This focus on sophisticated synthetic biology technologies and result-oriented project management has delivered project successes in the various virtual3C services…..”

At virtual3C, our initial focus has been in new product development in the areas of Biopharmaceuticals.

 The virtual3C platform is also used to produce a variety of solutions, from synthetically derived vaccines to prevent human diseases to environmental restoration. 

Leveraging the virtual3C platform, we have developed solutions across distinct industry domains. Leveraging the platform’s unique modular design unique solutions for gene and protein production capabilities have been ciustomised that address the specific needs of these markets :

Pharmaceutical companies that develop therapeutic proteins or use structure based drug design that drive products for development to clinical practice. Using software to design new microorganisms as vaccines.
Biotech
Bio-Fuel and  bio-based materials companies that convert biomass to products replacing fossil carbon sources.
Agriculture and food production companies using recombinant DNA to improve yields, bioprocess and reduce pesticide use.
Government Agencies  harnessing the power of genomics to manage risk – regulation and bio-safety.
Environmental restoration using metagenomic analysis.